Iridex Corp
IRIX- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001006045
In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Iridex Corp changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 32 | 30 | −2 |
| Shares | 3.68M | 3.53M | −148.9K (−4.0%) |
| Value | $17.0M | $9.07M | −$7.96M (−46.7%) |
New holders (1)
Institutions that held Iridex Corp at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Truvestments Capital LLC | 562 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Iridex Corp at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Conservest Capital Advisors, Inc. | 10,268 | $48.0K |
| JPMorgan Chase & Co | 3,601 | $17.0K |
| Simplex Trading, LLC | 450 | $2.00K |